OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2022
(4)
2018
(3)
2023
(2)
2025
(1)
2024
(1)
2019
(1)
2017
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.
Not available
S-EPMC5019744
|
biostudies-literature
Cite
Impact of Stage-Specific Guideline Concordant Treatment in Small Cell Lung Cancer in Victoria, Australia.
Not available
S-EPMC12425560
|
biostudies-literature
Cite
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.
Not available
S-EPMC9536193
|
biostudies-literature
Cite
Development of a binational thyroid cancer clinical quality registry: a protocol paper.
Not available
S-EPMC6352782
|
biostudies-literature
Cite
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper
Not available
S-EPMC9442481
|
biostudies-literature
Cite
The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours.
Not available
S-EPMC8995292
|
biostudies-literature
Cite
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).
Not available
S-EPMC9945618
|
biostudies-literature
Cite
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study.
Not available
S-EPMC10742146
|
biostudies-literature
Cite
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study.
Not available
S-EPMC11394053
|
biostudies-literature
Cite
Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper.
Not available
S-EPMC9438055
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets